Company CVAbout Dipna Pharmachem Ltd 
Dipna Pharmachem Ltd
Micro Cap
Pharmaceuticals & Drugs
Dipan Pharmachem Private Limited was incorporated on July 19, 2011. Subsequently, the Company name was changed to "Dipna Pharmachem Private Limited" on March 29, 2012. Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to "Dipna Pharmachem Limited" vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 24.05 Cr
Number of Shares
2.4 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-Feb-2024
2.4
24.05
12075250
10
Right Issues
06-Sep-2022
1.2
11.97
4002000
10
Public Issue
05-Sep-2022
1.2
11.97
4002000
10
Public Issue
14-May-2022
79.68
7.97
1328000
10
Bonus Issue
20-Apr-2022
66.4
6.64
4980000
10
Bonus Issue
05-Apr-2022
16.6
1.66
1625000
10
Right Issues
19-Jan-2016
35
0.04
25000
10
Preferential Allotment
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Keyur Dipakkumar Shah (9.97%)
Highest Public shareholder
Sunita Santosh Goenka (2.34%)
Individual Investors Holdings
81.82%
Board of Directors
Management
Designation
Remuneration
Keyur Shah
Managing Director
0
Dipna Shah
Director
0
Nandish Jani
Independent Director
0
Chinu Kalal
Independent Director
0
Khushboo Jethaliya
Company Sec. & Compli. Officer
0
Jitendra Parmar
Independent Director
0
Madhuri Gurwani
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Drugs
INR 38 Cr (Micro Cap)
35.00
33
0.00%
0.15
2.91%
1.02
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
